AMMONUL Drug Patent Profile
✉ Email this page to a colleague
When do Ammonul patents expire, and what generic alternatives are available?
Ammonul is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in AMMONUL is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMMONUL?
- What are the global sales for AMMONUL?
- What is Average Wholesale Price for AMMONUL?
Summary for AMMONUL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 2 |
Patent Applications: | 1 |
Drug Prices: | Drug price information for AMMONUL |
What excipients (inactive ingredients) are in AMMONUL? | AMMONUL excipients list |
DailyMed Link: | AMMONUL at DailyMed |
Recent Clinical Trials for AMMONUL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 2 |
Ucyclyd Pharma, Inc. | Phase 1 |
Horizon Pharma Ireland, Ltd., Dublin Ireland | Phase 1 |
Pharmacology for AMMONUL
Drug Class | Nitrogen Binding Agent |
Mechanism of Action | Ammonium Ion Binding Activity |
US Patents and Regulatory Information for AMMONUL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | AMMONUL | sodium benzoate; sodium phenylacetate | SOLUTION;INTRAVENOUS | 020645-001 | Feb 17, 2005 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |